山东大学耳鼻喉眼学报 ›› 2024, Vol. 38 ›› Issue (2): 13-17.doi: 10.6040/j.issn.1673-3770.0.2023.044

• 论著 • 上一篇    下一篇

疫苗相关性葡萄膜炎的临床特征分析:基于美国疫苗不良事件报告系统的回顾性研究

侯宁1,杨军兴2,张宇鹏1,林子淳1,邓爱军2   

  1. 临床医学院), 山东第二医科大学, 山东 潍坊 261000;
    2. 山东第二医科大学附属医院 眼科中心, 山东 潍坊 261000
  • 出版日期:2024-03-20 发布日期:2024-03-29
  • 通讯作者: 邓爱军. E-mail:dengaijun@hotmail.com

Analysis of clinical characteristics of vaccine-associated uveitis: a retrospective study based on American vaccine adverse event reporting system

HOU Ning1, YANG Junxing2, ZHANG Yupeng1, LIN Zichun1, DENG Aijun2   

  1. 1. Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang 261000, Shandong, China2. Ophthalmic Center, Affiliated Hospital of Shandong Second Medical University, Weifang 261000, Shandong, China
  • Online:2024-03-20 Published:2024-03-29

PDF (PC)

144

摘要： 目的 了解疫苗相关性葡萄膜炎的临床特征,为疫苗安全性监测、预防接种以及临床诊治提供参考。 方法 通过美国疫苗不良事件报告系统收集1990—2022年所有接种疫苗后发生葡萄膜炎的相关报告,并对接种者的性别、年龄、接种疫苗类型、疫苗剂次、葡萄膜炎发生时间以及葡萄膜炎类型进行回顾性分析。 结果 317例疫苗相关性葡萄膜炎病例中,共涉及10余种疫苗类型,主要为COVID-19疫苗、人乳头瘤病毒疫苗、乙型肝炎疫苗。男86例、女231例,男女比例为1∶2.7。18~<60岁接种者发生葡萄膜炎最多,占比65.3%。葡萄膜炎常见于接种疫苗后<8 d和第1剂疫苗接种后发生,分别占比56.8%和47.0%。184例葡萄膜炎类型分组报告中,虹膜睫状体炎占比最高,为56.5%。 结论 充分认识、深入研究接种疫苗的这一不良反应,持续开展疫苗安全性监测,更好进行预防接种以及临床诊治。

关键词: 疫苗, 葡萄膜炎, 疫苗不良事件报告系统, 不良反应

Abstract: Objective To investigate the clinical characteristics of vaccine-associated uveitis in order to provide a reference for vaccine safety monitoring, vaccination, and clinical diagnosis and treatment. Methods The vaccine-associated uveitis reports from 1990 to 2022 were collected from the American Vaccine Adverse Event Reporting System. Moreover, sex, age, type of vaccination, dose series, time of occurrence, and type of uveitis of vaccine-associated uveitis reports were retrospectively analyzed. Results Of the 317 cases of vaccine-associated uveitis, more than 10 types of vaccine were involved, mainly the COVID-19 vaccine, human papillomavirus vaccine, and hepatitis B vaccine. There were 86 males and 231 females, with a male-to-female ratio of 1:2.7. Patients aged 18-<60 years, accounted for the majority of the total cases(65.3%). Uveitis is common under 8 days after vaccination and after the first dose of vaccination, accounting for 56.8% and 47.0%, respectively. Iridocyclitis represented the highest proportion of 184(56.5%)cases of uveitis. Conclusion Fully understand and study this adverse reaction to vaccination in depth, continue to monitor vaccine safety, better vaccination, and clinical diagnosis and treatment.

Key words: Vaccine, Uveitis, Vaccine adverse event reporting system, Adverse reaction

中图分类号: 

  • R773
[1] Walton LR, Orenstein WA, Pickering LK. The history of the United States advisory committee on immunization practices(ACIP)[J]. Vaccine, 2015, 33(3): 405-414. doi:10.1016/j.vaccine.2014.09.043
[2] 马春霞, 周健. 引起葡萄膜炎的常见疫苗及发病机制[J]. 空军军医大学学报, 2023, 44(10): 1011-1015. doi:10.13276/j.issn.2097-1656.2023.10.019 MA Chunxia, ZHOU Jian. Common vaccines causing uveitis and their pathogenesis[J]. Journal of Air Force Medical University, 2023, 44(10): 1011-1015. doi:10.13276/j.issn.2097-1656.2023.10.019
[3] Benage M, Fraunfelder FW. Vaccine-associated uveitis[J]. Mo Med, 2016, 113(1): 48-52
[4] Kuniyoshi K, Hatsukawa Y, Kimura S, et al. Acute bilateral photoreceptor degeneration in an infant after vaccination against measles and Rubella[J]. JAMA Ophthalmol, 2017, 135(5): 478-482. doi:10.1001/jamaophthalmol.2017.0380
[5] Nyankerh CNA, Boateng AK, Appah M. Ocular complications after COVID-19 vaccination, vaccine adverse event reporting system[J]. Vaccines, 2022, 10(6): 941. doi:10.3390/vaccines10060941
[6] 张博, 郭代红, 郭海丽, 等. 基于美国疫苗不良事件报告系统的新型冠状病毒肺炎疫苗相关不良事件报告分析[J]. 中国药物应用与监测, 2021, 18(2): 114-117. doi: 10.3969/j.issn.1672-8157.2021.02.012 ZHANG Bo, GUO Daihong, GUO Haili, et al. Analysis of COVID-19 vaccine-related adverse event reports based on the American vaccine adverse event reporting system[J]. Chinese Journal of Drug Application and Monitoring, 2021, 18(2): 114-117. doi: 10.3969/j.issn.1672-8157.2021.02.012
[7] 刘云霞, 胡海鹏, 张秀萍. 223例急性前葡萄膜炎的临床特征及治疗分析[J]. 山东大学耳鼻喉眼学报, 2012, 26(4): 64-65. doi: 10.6040/j.issn.1673-3770.2012.04.025 LIU Yunxia, HU Haipeng, ZHANG Xiuping. Clinical characteristics and treatment of 223 patients with acute anterior uveitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2012, 26(4): 64-65. doi: 10.6040/j.issn.1673-3770.2012.04.025
[8] Singh RB, Parmar UPS, Kahale F, et al. Vaccine-associated uveitis after COVID-19 vaccination: vaccine adverse event reporting system database analysis[J]. Ophthalmology, 2023, 130(2): 179-186. doi:10.1016/j.ophtha.2022.08.027
[9] Agarwal M, Dutta Majumder P, Babu K, et al. Drug-induced uveitis: a review[J]. Indian J Ophthalmol, 2020, 68(9): 1799-1807. doi:10.4103/ijo.IJO_816_20
[10] Duffy J, Marquez P, Dores GM, et al. Safety surveillance of bivalent meningococcal group B vaccine, vaccine adverse event reporting system, 2014-2018[J]. Open Forum Infect Dis, 2020, 7(12): ofaa516. doi:10.1093/ofid/ofaa516
[11] Klein SL, Flanagan KL. Sex differences in immune responses[J]. Nat Rev Immunol, 2016, 16(10): 626-638. doi:10.1038/nri.2016.90
[12] 邢凯, 涂晓燕, 刘苗, 等. COVID-19疫苗的有效性和安全性的系统评价[J]. 中国当代儿科杂志, 2021, 23(3): 221-228. doi:10.7499/j.issn.1008-8830.2101133 XING Kai, TU Xiaoyan, LIU Miao, et al. Effcacy and safety of COVID-19 vaccines: a systematic review[J]. Chinese Journal of Contemporary Pediatrics, 2021, 23(3): 221-228. doi:10.7499/j.issn.1008-8830.2101133
[13] Fraunfelder FW, Suhler EB, Fraunfelder FT. Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports[J]. Cutan Ocul Toxicol, 2010, 29(1): 26-29. doi: 10.3109/15569520903427717
[14] 刘岩, 王节涛, 杨北方, 等. 基于2006—2021年疫苗不良事件报告系统的人乳头瘤病毒疫苗的安全性分析[J]. 中国生物制品学杂志, 2023, 36(8): 955-961. doi:10.13200/j.cnki.cjb.003760 LIU Yan, WANG Jietao, YANG Beifang, et al. Safety of human papilloma virus vaccine based on vaccine adverse event reporting system from 2006 to 2021[J]. Chinese Journal of Biologicals, 2023, 36(8): 955-961. doi:10.13200/j.cnki.cjb.003760
[15] Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA vaccine against SARS-CoV-2-preliminary report[J]. N Engl J Med, 2020, 383(20): 1920-1931. doi: 10.1056/NEJMoa2022483
[16] Pang KP, Pan LJ, Guo H, et al. Case report: associated ocular adverse reactions with inactivated COVID-19 vaccine in China[J]. Front Med(Lausanne), 2021, 8: 823346. doi:10.3389/fmed.2021.823346
[17] ElSheikh RH, Haseeb A, Eleiwa TK, et al. Acute uveitis following COVID-19 vaccination[J]. Ocul Immunol Inflamm, 2021, 29(6): 1207-1209. doi:10.1080/09273948.2021.1962917
[18] Renisi G, Lombardi A, Stanzione M, et al. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?[J]. Int J Infect Dis, 2021, 110: 95-97. doi:10.1016/j.ijid.2021.07.035
[19] Dansingani KK, Suzuki M, Naysan J, et al. Panuveitis with exudative retinal detachments after vaccination against human Papilloma virus[J]. Ophthalmic Surg Lasers Imaging Retina, 2015, 46(9): 967-970. doi:10.3928/23258160-20151008-11
[20] Cunningham ET, Moorthy RS. Vaccine-associated posterior uveitis[J]. Retin Cases Brief Rep, 2022, 16(1): 1-4. doi:10.1097/icb.0000000000000958
[21] 孙一鑫, 刘志科, 詹思延. 疫苗上市后安全性准实时监测的概括性评价[J]. 中国药物警戒, 2023, 20(1): 61-67. doi: 10.19803/j.1672-8629.20220619 SUN Yixin, LIU Zhike, ZHAN Siyan. Scoping review of near real-time surveillance of vaccine safety[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 61-67. doi: 10.19803/j.1672-8629.20220619
[22] Moro PL, Haber P, McNeil MM. Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention[J]. Expert Rev Vaccines, 2019, 18(10): 1091-1101. doi:10.1080/14760584.2019.1676154
[23] 刘砚韬, 林芸竹, 陈力, 等. 基于VAERS的轮状病毒疫苗不良反应信号挖掘和数据分析[J]. 中国医院药学杂志, 2021, 41(5): 527-532. doi:10.13286/j.1001-5213.2021.05.15 LIU Yantao, LIN Yunzhu, CHEN Li, et al. Data analysis and signal excavation of rotavirus vaccine induced ADR based upon the VAERS[J]. Chinese Journal of Hospital Pharmacy, 2021, 41(5): 527-532. doi:10.13286/j.1001-5213.2021.05.15
[1] 艾自琴,李军政. 免疫疫苗在头颈部鳞状细胞癌中的研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 143-150.
[2] 石博影,梁皓,李一洪,唐东永. Blau综合征成年患者抗青光眼手术后并发白内障手术治疗1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 60-65.
[3] 次仁琼达, 吴元. 中毒性表皮坏死松解症导致眼部远期并发症1例[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 147-150.
[4] 王坛,武珂,李连庆,宫丽丽. 皮下免疫治疗注射后出现全身不良反应的伴发因素及处理[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 71-74.
[5] 王增智. 免疫抑制对非感染性葡萄膜炎的治疗作用及对细胞因子的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(6): 64-67.
[6] 贺艳艳，肖淑烽，董彩蓉. 荧光素眼底血管造影后不良反应的影响因素[J]. 山东大学耳鼻喉眼学报, 2012, 26(5): 75-76.
[7] 陈秀丽，应良，原公强，董晓光. null[J]. 山东大学耳鼻喉眼学报, 2012, 26(5): 80-82.
[8] 丁凤奎1，苏万远2，李巧云1，李传宝2. 复合小梁切除术治疗前葡萄炎继发青光眼[J]. 山东大学耳鼻喉眼学报, 2011, 25(5): 105-.
[9] 杨珺1 ，孙嬿1，赵军1，韩敬力2. 葡萄膜炎继发青光眼并发白内障的手术治疗[J]. 山东大学耳鼻喉眼学报, 2010, 24(5): 53-55.
[10] 李丽丽1，毕宏生2，解孝锋2，郭俊国3. 清开灵眼用凝胶治疗慢性葡萄膜炎80例[J]. 山东大学耳鼻喉眼学报, 2010, 24(4): 62-.
[11] 蔡婉婷,毕宏生,吴建峰,解孝锋,刘冬梅 . 超声乳化术治疗葡萄膜炎并发性白内障39例[J]. 山东大学耳鼻喉眼学报, 2008, 22(1): 10-12 .
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 张晗,黄一飞 . 抗角膜移植排斥的研究进展[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 84 -87 .
[2] 牛善利,柴茂文,李振秀 . 鼻内镜下鼻甲成形术治疗慢性肥厚性鼻炎60例[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 16 -18 .
[3] 孟庆国,卢永田,范献良 . 杀伤细胞免疫球蛋白样受体基因多态性与鼻咽癌的关联性[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 196 -199 .
[4] 马玉起,孔祥春 . 先天性双侧下唇窦道1例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 199 -199 .
[5] 万俐佳,鲁海涛,姜义道,刘 辉,李 琴,佘腊枝 . 改良腭咽成形术治疗阻塞性睡眠呼吸暂停综合征41例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 204 -205 .
[6] 于青青 ,王跃建 . 硬质耳内镜的临床应用进展[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 222 -224 .
[7] 吉晓滨,邓家德,臧林泉,王 磊,谢 军 . 豚鼠变应性鼻炎模型血清组胺的测定[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 228 -230 .
[8] 向登,卢永田,孙焕吉 . 鼻内镜下修补脑脊液鼻漏19例并文献复习[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 234 -236 .
[9] 邱恩惠,李志春,方文旭 . 嗅觉障碍的中西医治疗[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 253 -257 .
[10] 殷国华,钟 笑 . 激光减容术治疗舌扁桃体肥大的远期疗效[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 280 -282 .
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发